NS · Pharmaceuticals

Mangalam Drugs & Organics Ltd (MANGALAM)

Pharmaceuticals & Biotechnology

Mangalam Drugs & Organics Ltd (MANGALAM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $468.70M, P/E ratio is -1.06, net margin is -6.4%, dividend yield is 1.69%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MANGALAM

Market cap

$468.70M

P/E ratio

-1.06

Net margin

-6.4%

Dividend yield

1.69%

Mangalam Drugs & Organics Ltd (MANGALAM) — FAQ

What is Mangalam Drugs & Organics Ltd's market cap?

Mangalam Drugs & Organics Ltd (MANGALAM) has a reported market cap of $468.70M (data as of 2026-07-10).

What is MANGALAM's P/E ratio?

The price-to-earnings (P/E) ratio for Mangalam Drugs & Organics Ltd (MANGALAM) is -1.06 (data as of 2026-07-10).

Does Mangalam Drugs & Organics Ltd pay a dividend?

Mangalam Drugs & Organics Ltd (MANGALAM) shows a reported dividend yield of 1.69%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Mangalam Drugs & Organics Ltd in?

Mangalam Drugs & Organics Ltd (MANGALAM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is MANGALAM listed on?

MANGALAM is listed on NS.

What is Mangalam Drugs & Organics Ltd's net margin?

Mangalam Drugs & Organics Ltd (MANGALAM) reports a net margin of -6.4% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)